We previously reported on allegations by the Royal Australian College of General Practitioners that Medicines Australia misled the ACCC in submitting its 18th Edition of the Code of Conduct.
Under the Code, healthcare professionals can elect to opt-out of being identified as having received payments in kind. The RACGP advocated that this undermined the value of transparency in reporting and only served to benefit pharmaceutical companies. In response, Medicines Australia reportedly submitted a document to the ACCC arguing that the collection of healthcare professionals’ personal information for transparency was only a secondary purpose for collecting the data and, as such, they cannot disclose personal information unless those health professionals consent. Dr Justin Coleman from the RACGP suggested the problem could be solved if healthcare professionals were asked to consent to transparency as a condition of receiving payment.
The ACCC is expected to make a decision about the Code later this month.
To view the Code, click here.